RNAi Therapeutics

Pages

▼
Showing posts with label ALN-PCS02. Show all posts
Showing posts with label ALN-PCS02. Show all posts
Friday, March 30, 2012

New Antibody Data Indicate Tough Battle for RNAi Therapeutic PCSK9 Approach

›
The past week has been a busy one for the hypercholesterolemia field. New clinical data for PCSK9-targeting monoclonal antibodies from Amge...
4 comments:
Wednesday, February 15, 2012

RNAi Therapeutics Financial Viability Looking Up Following String of Clinical Results

›
By: Dirk Haussecker Note: A PDF version of this article is available at myfirstnameDOTmylastnameATgmailDOTcom Abstract Shortly after the 200...
18 comments:
Wednesday, January 4, 2012

ALN-PCS02 Results Provide Glimpse of First RNAi Therapeutics Blockbuster

›
If the experts at Roche and other Big Pharma companies got you convinced that RNAi Therapeutics was about to disappear from the scene by pu...
10 comments:
Monday, November 7, 2011

RNAi Therapeutics Investors Hoping for a Merry Christmas

›
I’ve just come back from working at the Starbucks across my street which strongly reminded me that Christmas was just around the corner. Ch...
20 comments:
›
Home
View web version
Powered by Blogger.